Continued Process Verification for Biopharma Manufacturing
October 29, 2014 - BioPharm International
The authors discuss complications of implementing continued process verification and provide recommended approaches.
Oct 1, 2014
B
Biopharma Manufacturers Respond to Ebola Crisis
October 29, 2014 - Biopharm Intl
Demand for new therapies and vaccines spotlights production challenges.
Oct 1, 2014
By: Jill Wechsler
BioPharm Internati
Using Quality by Design to Develop Robust Chromatographic Methods
October 17, 2014 - Pharm Tech
Quality-by-design principles can be used to understand chromatographic measurement system variability.
Sep 2, 2014
By: Mel
A Q&A With Dr. Anurag Rathore About the Future of QbD, Part I
October 1, 2014 - BioPharm Intl.
This two-part Q&A series with Anurag Rathore, PhD, Professor, Department of Chemical Engineering, Indian Institute of Technology, Delhi, reveals the evo
…
Challenges and Trends in Biopharma Facility Design
October 1, 2014 - BioPharm Intl.
Experts discuss the future of modular manufacturing and the challenges that biopharma manufacturers face in facility design.
Sep 1,
…
Evaluating Design Margin, Edge of Failure and Process
September 18, 2014 - BioPharm Intl.
Design space generation is encouraged in new product development.
Sep 1, 2014
By: Thomas A. Little, PhD
BioPharm
Healthcare Reform in China
September 18, 2014 - BioPharm Intl.
Chinese healthcare reforms may be a double-edged sword for foreign companies.
Sep 1, 2014
By: Jane Wan
BioPharm
Challenges of Protein Aggregation During Purification
September 18, 2014 - BioPharm Intl.
Careful selection of downstream processing conditions is a must.
Sep 1, 2014
By: Cynthia Challener, PhD
BioPharm
Relationship Building at Top of Mind for Clients
September 4, 2014 - BioPharm Intl.
Annual study shows technical expertise is not enough.
Aug 1, 2014
By: Eric Langer
BioPharm International
V
Pharma Investments Reflect Key Industry Trends
September 4, 2014 - Pharm Tech
Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
Aug 2, 2014
By: Cyn